|
POFUT1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.130100E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.055900E-03 |
| Normal-vs-Stage2 |
2.277800E-01 |
| Normal-vs-Stage3 |
5.894800E-01 |
| Normal-vs-Stage4 |
2.471600E-01 |
| Stage1-vs-Stage2 |
8.957200E-01 |
| Stage1-vs-Stage3 |
1.044950E-01 |
| Stage1-vs-Stage4 |
9.518800E-01 |
| Stage2-vs-Stage3 |
2.400000E-01 |
| Stage2-vs-Stage4 |
8.925000E-01 |
| Stage3-vs-Stage4 |
3.030800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.111780E-01 |
| Normal-vs-AfricanAmerican |
6.707600E-02 |
| Normal-vs-Asian |
6.233500E-04 |
| Caucasian-vs-AfricanAmerican |
5.707600E-01 |
| Caucasian-vs-Asian |
2.929600E-01 |
| AfricanAmerican-vs-Asian |
2.692400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.795300E-04 |
| Normal-vs-Female |
2.049000E-01 |
| Male-vs-Female |
3.563300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.803400E-01 |
| Normal-vs-Extreme_Weight |
5.322200E-03 |
| Normal-vs-Obese |
8.214600E-01 |
| Normal-vs-Extreme_Obese |
5.949800E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.485000E-01 |
| Normal_Weight-vs-Obese |
5.624400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.273400E-01 |
| Extreme_Weight-vs-Obese |
5.012000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.547800E-01 |
| Obese-vs-Extreme_Obese |
1.675020E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.686800E-01 |
| Normal-vs-Age(41-60Yrs) |
9.057000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.560670E-03 |
| Normal-vs-Age(81-100Yrs) |
4.36000000000325E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.402000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.031800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.216400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.182000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.940110E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.290000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.079800E-02 |
| Normal-VS-Type2 PRCC |
6.383500E-03 |
| Normal-VS-KIRP CIMP |
8.596000E-01 |
| Normal-VS-Unclassified PRCC |
1.468570E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.068800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.010000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.863520E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.014200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.282100E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.302600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.479300E-03 |
| Normal-vs-N1 |
4.683000E-01 |
| Normal-vs-N2 |
3.549000E-01 |
| N0-vs-N1 |
2.076100E-02 |
| N0-vs-N2 |
2.193000E-01 |
| N1-vs-N2 |
9.961200E-01 |
|
|
